The Talent Pool - The weather might leave something to be desired, but it would take more than the occasional shower to stem the flow of talent into Scotland. - BioPharm International

ADVERTISEMENT

The Talent Pool
The weather might leave something to be desired, but it would take more than the occasional shower to stem the flow of talent into Scotland.

BioPharm International


Professor Dominiczak believes strongly in the interconnectivity of scientific research. She feels strongly that one of the advantages of the active life sciences community in the West of Scotland is the opportunity available to all to draw together the threads of many different research projects.

"Regardless of technology, life-changing discoveries are often made while chatting over a cup of coffee," she says. "The friendly environment surrounding the new center greatly facilitates both the formal and informal sharing of knowledge."

Professor Walter Kolch


Kolch
Professor of Biomedical and Life Sciences at the University of Glasgow and group leader at the Beatson Institute, Glasgow, Professor Walter Kolch has a world-class reputation for his research in proteomics, cell signaling, and analytical biochemistry. His work centers on the principles of cancer growth and transformation and, in particular, of signal transduction pathways, or intercellular channels of communication.

Born and educated in Austria, Professor Kolch worked extensively in both the US and Germany before moving to the Beatson Institute for Cancer Research ( http://www.beatson.gla.ac.uk/) in Glasgow in 1998. He was appointed Professor of Molecular Cell Biology at the University of Glasgow in 2000.

Professor Kolch is also a highly successful manager of research projects and was the lead applicant in the successful funding application, which led to the establishment of the Sir Henry Wellcome Functional Genomics Facility (SHWFGF) at the University of Glasgow in 2001.

Professor Kolch points out that an essential part of scientific research is teamwork. His base in the West of Scotland places him at the forefront of biochemistry and signal transduction research/proteomics in Europe.

Not least among the advantages he finds here is the approximately $21-million grant made in 2005 by the Biotechnology and Biological Sciences Research Council and the Engineering and Physical Sciences Research Council—two of the most important granting institutions in the UK—for the development of proteomics technologies over a six-year period. This is a joint project involving researchers from three Scottish universities in Glasgow, Edinburgh, and Dundee.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Baxter Initiates Voluntary Recall of Potassium Chloride Injection
September 17, 2014
PDA Announces Technical Report on Drug Shortages
September 9, 2014
European Commission Approves RoACTEMRA for Treatment of RA
September 9, 2014
FDA Releases Guidance Electronic Submission of Lot Distribution Reports
September 5, 2014
Infinity and AbbVie Collaborate to Develop Oncology Drug
September 5, 2014
Author Guidelines
Source: BioPharm International,
Click here